GlassScriptPhysician profile
Annie Jiang
NPI 1750192068
$1,603.30
in general payments reported to CMS, 2019-2025
15 companies · $1,603 in 2025
The $1,603 reported for 2025 was more than what 92% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,603.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,503 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,503.31 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $289.20 | 2025 | Nemluvio |
| Genzyme Corporation | $209.43 | 2025 | |
| Organon LLC | $158.69 | 2025 | Vtama |
| Glaxosmithkline, LLC. | $153.03 | 2025 | Trelegy Ellipta |
| Madrigal Pharmaceuticals | $129.87 | 2025 | Rezdiffra |
| Astrazeneca Pharmaceuticals LP | $107.35 | 2025 | Fasenra |
| Sanofi-Aventis U.S. LLC | $99.99 | 2025 | |
| Biocryst US Sales Co., LLC | $73.09 | 2025 | Orladeyo |
| Ars Pharmaceuticals Operations, INC. | $71.56 | 2025 | Neffy |
| Regeneron Healthcare Solutions, INC. | $67.47 | 2025 | Dupixent |
| Novartis Pharmaceuticals Corporation | $61.90 | 2025 | |
| Arcutis Biotherapeutics, INC. | $60.49 | 2025 | Zoryve |
| Incyte Corporation | $49.84 | 2025 | Opzelura |
| Leo Pharma INC. | $47.93 | 2025 | Anzupgo |
| Optinose US, INC. | $23.46 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Annie Jiang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.